Insider screener

Period: 12 months + Add filter
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

59,448 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

59,448 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

59,448 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

59,448 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
59,448 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
59,448 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

59,448 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Feb 2026
Cynthia B Powell Corp. Controller & CAO
Sold at will
$183.72K 3,500 at 52.49
84.0%
Sold half or more
2 Feb 2026
Gabriel Brooks Chief Medical Officer
Sold on a plan
$182.39K 28,335 at 6.44
22.7%
Planned (10b5-1)
2 Feb 2026
Chad Roberts EVP, Production Solutions
Sold on a plan
$178.04K 8,300 at 21.45
6.4%
Planned (10b5-1)
2 Feb 2026
Lisa M O'Neill EVP & CFO
Sold at will
$176.15K 2,900 at 60.74
7.8%
Not planned
2 Feb 2026
James Andrew Pierce Group President
Sold at will
$175.21K 475 at 368.87
0.7%
Not planned
2 Feb 2026
Joseph D Mansueto Executive Chairman
Sold on a plan 2×
$173.44K 857 at 202.38
0.0%
Planned (10b5-1)
2 Feb 2026
Kevin Tan CFO & Treasurer
Sold on a plan
$172.75K 26,837 at 6.44
19.8%
Planned (10b5-1)
2 Feb 2026
Marci A Basich Chief Financial Officer/EVP
Sold at will
$171.79K 4,347 at 39.52
47.5%
Not planned
2 Feb 2026
David D Chang President and CEO
Sold at will
$171.48K 95,269 at 1.80
1.8%
Not planned
2 Feb 2026
Jessie Hanrahan Chief Regulatory Officer
Sold on a plan
$170.80K 26,535 at 6.44
24.3%
Planned (10b5-1)
2 Feb 2026
Vicki L Sato Director
Sold on a plan
$169.67K 22,000 at 7.71
1.9%
Planned (10b5-1)
2 Feb 2026
Paul Herzich Chief Technology Officer
Sold on a plan
$168.97K 26,250 at 6.44
24.7%
Planned (10b5-1)
2 Feb 2026
Michael George Rosenbaum Chief Executive Officer
Sold on a plan
$168.01K 1,200 at 140.01
0.5%
Planned (10b5-1)
2 Feb 2026
Robert J Gould Director
Sold at will
$160.86K 15,000 at 10.72
3.2%
Not planned
2 Feb 2026
John R. Taylor EVP and Controller
Sold at will
$158.64K 704 at 225.34
12.4%
Not planned
2 Feb 2026
Rudina Seseri Director
Sold at will
$156.29K 1,800 at 86.83
22.8%
Not planned
2 Feb 2026
Matthew J DeBord Chief Lending Officer, EVP
Sold at will
$150.41K 3,805 at 39.53
40.0%
Not planned
2 Feb 2026
Surya Gummadi President - Americas
Sold on a plan
$143.52K 1,728 at 83.06
6.3%
Planned (10b5-1)
2 Feb 2026
Joseph H. Griffith IV Chief Financial Officer
Sold at will
$143.22K 23,175 at 6.18
14.2%
Not planned
2 Feb 2026
Paul D Rubin Chief Medical Officer
Sold on a plan
$139.37K 7,433 at 18.75
100%
Sold half or more
2 Feb 2026
John Wendell Thompson Director · indirect
Sold on a plan 3×
$138.26K 2,500 at 55.30
8.8%
Planned (10b5-1)
2 Feb 2026
Steven W Moster Director
Bought
$136.87K 300 at 456.23
11.2%
First buy on file
2 Feb 2026
Bought
$134.22K 18,985 at 7.07
1.5%
First buy on file
2 Feb 2026
Priya Singhal Head of Development
Sold on a plan
$134.12K 748 at 179.30
10.7%
Planned (10b5-1)
2 Feb 2026
Terrance Lane Wilson SVP & General Counsel
Sold at will
$132.78K 2,000 at 66.39
0.7%
Not planned
2 Feb 2026
Jane Henderson Chief Financial Officer
Sold on a plan 3×
$131.63K 2,000 at 65.81
1.1%
Planned (10b5-1)
2 Feb 2026
Sold at will
$126.84K 7,039 at 18.02
1.9%
Not planned
2 Feb 2026
Sold on a plan
$126.79K 1,125 at 112.70
1.0%
Planned (10b5-1)
2 Feb 2026
Aminta K Conant Director
Bought
$126.00K 4,000 at 31.50
56.7%
Largest buy in 3 yrs
2 Feb 2026
Jennifer Vecchio Group President and CMO
Sold on a plan 5×
$124.69K 419 at 297.60
0.7%
Planned (10b5-1)
2 Feb 2026
Shane Kapral Deputy Chief Financial Officer
Sold on a plan
$124.46K 616 at 202.04
17.9%
Planned (10b5-1)
2 Feb 2026
Beth Hecht See Remarks
Sold at will
$124.15K 16,667 at 7.45
1.3%
Not planned
2 Feb 2026
Sold on a plan
$120.59K 10,000 at 12.06
0.5%
Planned (10b5-1)
2 Feb 2026
Barry M Smith Director
Sold on a plan
$120.08K 700 at 171.54
2.9%
Planned (10b5-1)
2 Feb 2026
Paul McNab EVP, Chief Mktg & Stgy Officer
Sold at will
$119.66K 4,638 at 25.80
17.6%
Not planned
2 Feb 2026
Nicholas Grund Chief Commercial Officer
Sold on a plan 2×
$117.91K 84,829 at 1.39
13.1%
Planned (10b5-1)
2 Feb 2026
Longitude Capital Partners II, LLC 10% owner · indirect
Sold at will
$116.77K 27,500 at 4.25
26.4%
Not planned
2 Feb 2026
Eagle Point Credit Management LLC 10% owner · indirect
Sold at will
$114.97K 5,200 at 22.11
0.7%
Not planned
2 Feb 2026
Aqua Capital, Ltd. 10% owner
Bought
$112.36K 5,000 at 22.47
0.1%
First buy on file
2 Feb 2026
Rebecca L Charlton SVP, Controller & CAO
Sold on a plan
$110.70K 1,985 at 55.77
14.1%
Planned (10b5-1)
2 Feb 2026
Gary K. Schick SVP, CHRO
Sold on a plan 7×
$102.87K 422 at 243.77
1.0%
Planned (10b5-1)
2 Feb 2026
Sold at will
$102.17K 20,070 at 5.09
12.7%
Not planned
2 Feb 2026
Saba Capital Management, L.P. 10% owner · indirect
Sold at will
$100.06K 12,430 at 8.05
0.7%
Not planned
2 Feb 2026
Jolanda Howe SVP, Global Controller
Sold at will
$100.00K 968 at 103.30
17.7%
Not planned
2 Feb 2026
Carolyn M. Rucci SVP, Chief Legal Officer
Sold on a plan 3×
$96.98K 69,772 at 1.39
10.6%
Planned (10b5-1)
2 Feb 2026
Shaunt Voskanian Chief Revenue Officer
Sold at will 2×
$95.17K 3,828 at 24.86
0.2%
Not planned
2 Feb 2026
Steven Keith Burke SVP, Chief Medical Officer
Sold on a plan 3×
$94.04K 67,658 at 1.39
6.7%
Planned (10b5-1)
2 Feb 2026
Patrick Burnett See Remarks
Sold on a plan
$93.71K 3,675 at 25.50
3.9%
Planned (10b5-1)
2 Feb 2026
Eric Ellingsen Executive VP &
Sold at will
$93.06K 1,519 at 61.27
3.6%
Not planned
2 Feb 2026
Leila Alland Director
Sold at will
$91.96K 18,065 at 5.09
9.4%
Not planned
Showing 45,601–45,650 of 59,448. ← Newer Page 913 of 1,189 Older →